Based on the Instil Bio Inc. stock forecast from 2 analysts, the average analyst target price for Instil Bio Inc. is USD 52.00 over the next 12 months. Instil Bio Inc.’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Instil Bio Inc. is Slightly Bearish, which is based on 4 positive signals and 6 negative signals. At the last closing, Instil Bio Inc.’s stock price was USD 16.48. Instil Bio Inc.’s stock price has changed by +21.27% over the past week, -17.10% over the past month and +57.85% over the last year.
Past 12 monthsNext 12 months
No recent analyst target price found for Instil Bio Inc.
No recent average analyst rating found for Instil Bio Inc.
Company Overview Instil Bio Inc.
Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. The company develops cell therapy of tumor infiltrating lymphocyte (TIL) for the treatment of cancer. It is developing early-stage pipeline of CoStAR-TIL and other novel TIL technologies. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas. Read Less
Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. The company develops cell therapy of tumor infiltrating lymphocyte (TIL) for the treatment of cancer. It is developing early-stage pipeline of CoStAR-TIL and other n...Read More
Frequently Asked Questions About Instil Bio Inc. (TIL) Stock
Based on ratings from 2 analysts Instil Bio Inc.'s stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 2 buy, sell and hold ratings.
Unfortunately we do not have enough data on TIL's stock to indicate if its a good dividend stock.
Based on targets from 2 analysts, the average taret price for TIL is USD 52.00 over the next 12 months. The maximum analyst target price is USD 52 while the minimum anlayst target price is USD 52.
TIL stock's Price/Earning ratio is 7.94.
Our analysis grades TIL stock's Price / Earning ratio at F. This means that TIL stock's Price/Earning ratio is above 53% of the stocks in the Biotechnology sector in the NSD exchange.
Based on this TIL may be a overvalued for its sector.
The last closing price of TIL's stock was USD 16.48.
The most recent market capitalization for TIL is USD 0.13B.
Based on targets from 2 analysts, the average taret price for TIL is projected at USD 52.00 over the next 12 months.
This means that TIL's stock price may go up by +215.53% over the next 12 months.
We can't find any ETFs which contains Instil Bio Inc.'s stock.
As per our most recent records Instil Bio Inc. has 14 Employees.
Instil Bio Inc.'s registered address is 3963 Maple Avenue, Dallas, TX, United States, 75219.
You can get more information about it from Instil Bio Inc.'s website at https://instilbio.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Instil Bio Inc. (TIL) Stock
Based on ratings from 2 analysts Instil Bio Inc.'s stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 2 buy, sell and hold ratings.
Unfortunately we do not have enough data on TIL's stock to indicate if its a good dividend stock.
Based on targets from 2 analysts, the average taret price for TIL is USD 52.00 over the next 12 months. The maximum analyst target price is USD 52 while the minimum anlayst target price is USD 52.
TIL stock's Price/Earning ratio is 7.94.
Our analysis grades TIL stock's Price / Earning ratio at F. This means that TIL stock's Price/Earning ratio is above 53% of the stocks in the Biotechnology sector in the NSD exchange.
Based on this TIL may be a overvalued for its sector.
The last closing price of TIL's stock was USD 16.48.
The most recent market capitalization for TIL is USD 0.13B.
Based on targets from 2 analysts, the average taret price for TIL is projected at USD 52.00 over the next 12 months.
This means that TIL's stock price may go up by +215.53% over the next 12 months.
We can't find any ETFs which contains Instil Bio Inc.'s stock.
As per our most recent records Instil Bio Inc. has 14 Employees.
Instil Bio Inc.'s registered address is 3963 Maple Avenue, Dallas, TX, United States, 75219.
You can get more information about it from Instil Bio Inc.'s website at https://instilbio.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for TIL !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
